Stroke patients: Do they have a predilection for extrapyramidal side effects from amiodarone?

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 1, 1999, Pages 112-114

  Katrak, Pesi H ^a  

^a PRINCE HENRY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; RISK ASSESSMENT; RISK FACTOR; STROKE;

EID: 0032951874     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90317-9     Document Type: Article

References (7)

1. Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J 1991;121:158-71.
2. Charness ME, Morady F, Scheinman MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 1984;34: 669-71.
3. Palakurthy PR, Iyer V, Mackler RJ. Unusual neurotoxicity associated with amiodarone therapy. Arch Intern Med 1987;147:881-4.
4. Malaterre HR, Renou C, Kallee K, Gauthier A. Akinesia and amiodarone therapy. Int J Cardiol 1997;59:107-8.
5. Werner EG, Olanow CW. Parkinsonism and amiodarone therapy. Ann Neurol 1989;25:630-2.
6. Coulter DM, Edwards IR, Savage RL. Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme. N Z Med J 1990;103:98-100.
7. Shukla R, Jowlett NI, Thompson DR, Poli JE. Side effects with amiodarone therapy. Postgrad Med J 1994;70:492-8.